Jacobus A. Burgers

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Pre-treatment Tumor Volume Growth Rate and Baseline Volume Measured by an Artificial Intelligence Program Predict Overall Survival in Patients With Pleural Mesothelioma Undergoing Deferred Systemic Therapy.

Pre-treatment Tumor Volume Growth Rate and Baseline Volume Measured by an Artificial Intelligence Program Predict Overall Survival in Patients With Pleural Mesothelioma Undergoing Deferred Systemic Therapy.

Journal: JTO clinical and research reports

Published: February 03, 2026

Assessing the reliability of Response Evaluation Criteria In Solid Tumors (RECIST): a systematic review of the factors contributing to inter-observer variability.

Assessing the reliability of Response Evaluation Criteria In Solid Tumors (RECIST): a systematic review of the factors contributing to inter-observer variability.

Journal: Insights into imaging

Published: December 22, 2025

Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?

Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 16, 2025

Clinical validation and implementation of mSTOP, a machine learning-based, longitudinal prediction model for the early identification of non-small cell lung cancer patients who not benefit from immune checkpoint inhibitor treatment.

Clinical validation and implementation of mSTOP, a machine learning-based, longitudinal prediction model for the early identification of non-small cell lung cancer patients who not benefit from immune checkpoint inhibitor treatment.

Journal: Clinical chemistry and laboratory medicine

Published: December 05, 2025

Epidemiology of asbestosis in the Netherlands: a 10-year cohort analysis.

Epidemiology of asbestosis in the Netherlands: a 10-year cohort analysis.

Journal: ERJ open research

Published: December 02, 2025

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Journal: The Lancet. Oncology

Published: October 15, 2025

Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series.

Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series.

Journal: JTO clinical and research reports

Published: June 23, 2025

Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review.

Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review.

Journal: Translational lung cancer research

Published: June 20, 2025

The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort study.

The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort study.

Journal: ERJ open research

Published: June 05, 2025

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.

Journal: The Lancet. Oncology

Published: April 07, 2025

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands.

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands.

Journal: Scientific reports

Published: March 10, 2025

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.

Journal: Clinical pharmacology and therapeutics

Published: February 03, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026